Microencapsulation produces uniform drug release vehicle

Microencapsulation produces uniform drug release vehicle


The current treatment for brain tumors is
after surgical removal of the tumor sites, typically radiation therapy happens first.
Second, or the last stage is chemotherapeutic agents. And typically, the chemotherapeutic agents
are delivered through the intravenous delivery — IV delivery. There are a lot of problems
associated with IV injections, such as side effects. The technique that we use here is encapsulation
of the anti-cancer agent within the polymeric matrices. And during this process, we are
making microcapsules. They can be delivered through the catheter directly to the tumor
site, instead of delivery to the blood stream. So we are bypassing those barriers. So in
that case, we can administer directly the drug in the tumor site and prevent those side
effects. So with this technique, we were able to generate
microcapsules with the anti-cancer agent inside the microcapsules with three major characteristics:
one is control on the size, shape and drug encapsulations. The fabrication process for the development
of microcapsules, drug-loaded microcapsules is through the electrojetting process. Through
this process, we have a solution containing the polymer and the drug, which are mixed
together. Any by injecting through a syringe and creating high voltage between the syringe
and the target, we can directly electrospray or electrospin fibers and droplets on the
target. So the ultimate goal of drug delivery is to
provide the right amount of drug in the right time in the right location. So with the control
in the size, and the shape and the loading capacity, we can predict how much drug we
can deliver in the tumor site.

Leave a Reply

Your email address will not be published. Required fields are marked *